Maternal serum thromboxane B2 concentrations do not predict improved outcomes in high-risk pregnancies in a low-dose aspirin trial. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medical Units.

Maternal serum thromboxane B2 concentrations do not predict improved outcomes in high-risk pregnancies in a low-dose aspirin trial. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medical Units. Am J Obstet Gynecol. 1998 Nov; 179(5):1193-9.

View in: PubMed

subject areas

Aspirin
Cyclooxygenase Inhibitors
Dose-Response Relationship, Drug
Double-Blind Method
Female
Humans
Osmolar Concentration
Predictive Value of Tests
Pregnancy
Pregnancy Outcome
Risk Factors
Thromboxane B2

authors with profiles

Marshall Lindheimer